Indian equities continued to hit new highs for yet one more session on Monday amid constructive international cues. On the shut, Nifty ended 0.13 per cent greater at 20,997, whereas Sensex rallied 0.15 per cent and settled at 69,928.5, after hitting 70,000 milestone in intra-day commerce. In the meantime, following sentiment, Financial institution Nifty additionally marked a brand new excessive.
Listed below are the highest 10 shares in deal with Monday (December 11):
Tata Energy: Shares of the utility firm ended over 3 per cent greater after inking a contract with IOC.
Financial institution of India: From the PSU Banking basket, Financial institution of India gained 3.6 per cent to Rs 118.4, mirroring sentiment within the broader Nifty PSU Financial institution index.
Subros: After the ministry of highway transport iterated that every one new vehicles ought to be geared up with AC cabins for driver, the inventory ended 11 per cent greater at Rs 499.6 apiece.
Mahindra, Ashok Leyland: Tata Motors: Shares of the truck producers ended combined even because the set up of AC fitted driver cabins would imply additional prices for these corporations.
Inexpensive Robotic: Shares of the BSE-listed industrial gear firm ended with over 7 per cent good points because the entity forayed into machine store automation.
Century Plyboards: Shares of the wooden merchandise firm ended with over 7 per cent good points at Rs 737.15 amid heavy volumes.
Wockhardt: Shares of the drug maker after hitting 52-week excessive ended over 14 per cent greater at Rs 383.5 as the corporate accomplished the section 3-trial of pneumonia drug.
OMC shares: Shares of the oil advertising and marketing corporations ended within the pink as media stories recommend that the centre is mulling decreasing gas costs.
Spicejet: The airline’s shares ended over 10 per cent greater at Rs 60.57 as the corporate’s board is about to fulfill right now for mulling fund elevating.
Dr Reddy’s: Shares of the pharma firm ended 5 per cent decrease at Rs 5473.5 because the US FDA has issued type 483 with three observations on the corporate.